These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 32495949)
1. Defibrillators in adult congenital heart disease: Long-term risk of appropriate shocks, inappropriate shocks, and complications. Moore BM; Cao J; Cordina RL; McGuire MA; Celermajer DS Pacing Clin Electrophysiol; 2020 Jul; 43(7):746-753. PubMed ID: 32495949 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes. Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868 [TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. Vehmeijer JT; Brouwer TF; Limpens J; Knops RE; Bouma BJ; Mulder BJ; de Groot JR Eur Heart J; 2016 May; 37(18):1439-48. PubMed ID: 26873095 [TBL] [Abstract][Full Text] [Related]
4. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD). Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514 [TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillator therapy to reduce sudden cardiac death in adults with congenital heart disease: A registry study. Slater TA; Cupido B; Parry H; Drozd M; Blackburn ME; Hares D; Pepper CB; Birkitt L; Cullington D; Witte KK; Oliver J; English KM; Sengupta A J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2086-2092. PubMed ID: 32583559 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator. Coutinho Cruz M; Viveiros Monteiro A; Portugal G; Laranjo S; Lousinha A; Valente B; Osório P; Silva Cunha P; de Sousa L; Oliveira JA; Agapito A; Martins Oliveira M; Pinto F; Cruz Ferreira R Congenit Heart Dis; 2019 Jul; 14(4):525-533. PubMed ID: 30889316 [TBL] [Abstract][Full Text] [Related]
7. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease. Kella DK; Merchant FM; Veledar E; Book W; Lloyd MS Pacing Clin Electrophysiol; 2014 Nov; 37(11):1492-8. PubMed ID: 24889130 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638 [TBL] [Abstract][Full Text] [Related]
9. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks? Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209 [TBL] [Abstract][Full Text] [Related]
10. Outcomes following the implantation of cardioverter-defibrillator for primary prevention in transposition of the great arteries after intra-atrial baffle repair: a single-centre experience. Buber J; Ackley TJ; Daniels CJ; Roble SL; Mah ML; Kamp AN; Kertesz NJ Europace; 2016 Jul; 18(7):1016-22. PubMed ID: 26705566 [TBL] [Abstract][Full Text] [Related]
12. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease. Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513 [TBL] [Abstract][Full Text] [Related]
13. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121 [TBL] [Abstract][Full Text] [Related]
14. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Yap SC; Roos-Hesselink JW; Hoendermis ES; Budts W; Vliegen HW; Mulder BJ; van Dijk AP; Schalij MJ; Drenthen W Eur Heart J; 2007 Aug; 28(15):1854-61. PubMed ID: 17030523 [TBL] [Abstract][Full Text] [Related]
15. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies. Garnreiter JM; Pilcher TA; Etheridge SP; Saarel EV Heart Rhythm; 2015 May; 12(5):937-42. PubMed ID: 25620047 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811 [TBL] [Abstract][Full Text] [Related]